Print
The drug Enhertu is FDA-approved for any advanced or metastatic HER2-positive tumors
https://www.facingourrisk.org/XRAY/Enhertu-for-metastatic-HER2-positive-cancer
Full article: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
The FDA granted accelerated approval of Enhertu for people with any HER2-positive tumor that is metastatic or cannot be surgically removed. Eligible patients must have had previous treatment such as chemotherapy or hormone therapy. (Posted 7/19/24)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- Have I had tumor testing?
- Is my tumor HER2-positve?
- Is Enhertu right for me?
- What options do I have before trying Enhertu?
- Am I a candidate for Enhertu if I have a history of lung issues?
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.